Research Activity – Page 74

Pfizer Temporarily Suspends Dosing in Advanced Duchenne Muscular Dystrophy (DMD) Trial After Patient Fatality

1 year ago talkbio0Tagged Clinical Trials, concerns, DMD, dosing, Duchenne, Evaluation, halt, late-stage study, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Pfizer, Safety, Suspensions, Transitory

Pfizer, Duchenne Muscular Dystrophy (DMD), clinical trial, dosing halt, patient death, late-stage study, temporary suspension, safety concerns, investigation.

Lykos Therapeutics’ MDMA-Assisted Therapy for PTSD: Awaiting FDA Advisory Committee Review

1 year ago talkbio0Tagged Advisory Committees, Clinical Trials, Drug Approval, Lykos ', MDMA-assisted therapy, Post-Traumatic Stress Disorder, United States Food and Drug Administration

Lykos Therapeutics, MDMA-assisted therapy, PTSD treatment, FDA Advisory Committee, clinical trials, drug approval process.

FDA Panel to Evaluate Lykos’ Innovative Psychedelic Treatment for Post-Traumatic Stress Disorder

1 year ago talkbio0Tagged Clinical Trials, Lykos ', mental health, mental health breakthrough, Post-Traumatic Stress Disorder, psychedelic therapy, review panel, United States Food and Drug Administration

FDA, Lykos, psychedelic therapy, PTSD, mental health, clinical trials, review panel, innovative treatment, mental health breakthrough.

ADC Therapeutics Showcases Promising Zynlonta Data in Marginal Zone Lymphoma and Secures $105M in Funding

1 year ago talkbio0Tagged Antibody-Drug Conjugates, Biotechnology, Cancer Therapeutic Procedure, Clinical Trials, Health care facility, Mucosa-Associated Lymphoid Tissue Lymphoma, Sales - occupational activity, therapeutic autologous dendritic cells, Zynlonta

ADC Therapeutics, Zynlonta, marginal zone lymphoma, share sale, funding, cancer treatment, antibody-drug conjugate, clinical trials, biotechnology, healthcare.

Novo, Gates, and Wellcome Join Forces with $300 Million Initiative to Tackle Global Infectious Diseases

1 year ago talkbio0Tagged Collaboration, Communicable Diseases, development aspects, Global Health, Holdings, Melinda, Microbicides, pandemic preparedness, research, Resistance (Psychotherapeutic), Trust (Social Behavior), Wellcome

Novo Holdings, Bill & Melinda Gates Foundation, Wellcome Trust, infectious diseases, global health, pandemic preparedness, antimicrobial resistance, research and development, funding, collaboration.

Chiesi Invests Heavily in Gossamer’s Promising Pulmonary Hypertension Treatment

1 year ago talkbio0Tagged Cardiovascular Diseases, Chiesi, Clinical Trials, Collaboration, Drug Development, GD-001, Gossamer, Investments, Pulmonary Hypertension

Chiesi, Gossamer, pulmonary hypertension, drug development, investment, collaboration, GD-001, clinical trials, cardiovascular diseases.

GlycoMimetics’ Uproleselan Fails to Meet Primary Endpoint in Leukemia Clinical Trial

1 year ago talkbio0Tagged Clinical Trials, GlycoMimetics, leukemia, Primary Endpoint, Stock Market Reaction, Uproleselan

GlycoMimetics, Uproleselan, Leukemia, Clinical Trial, Primary Endpoint, Stock Market Reaction

AstraZeneca Strengthens Partnership with Cellectis in Cell and Gene Therapy Advancement

1 year ago talkbio0Tagged AstraZeneca, Biotechnology, Cell Therapy, Cellectis, development aspects, Discover, gene therapy, Health care facility, innovation, Investments, Medical Research activity, Papillary thyroid carcinoma, Partnership, stake

AstraZeneca, Cellectis, cell therapy, gene therapy, partnership, stake, discovery, pact, biotechnology, healthcare, investment, innovation, medical research, therapeutic development.